We updated the design of this site on September 25th. Learn more.

A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL

This study has been terminated.

(Toxicity)

Sponsor:

ClinicalTrials.gov Identifier:

NCT01483690

First Posted: December 1, 2011

Last Update Posted: November 24, 2015

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Information provided by (Responsible Party):

Therapeutic Advances in Childhood Leukemia Consortium

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been terminated.
Study Completion Date:	No date given
Primary Completion Date:	June 2015 (Final data collection date for primary outcome measure)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Raetz EA, Bhatla T. Where do we stand in the treatment of relapsed acute lymphoblastic leukemia? Hematology Am Soc Hematol Educ Program. 2012;2012:129-36. doi: 10.1182/asheducation-2012.1.129. Review.

To Top